Content about Novartis

May 22, 2013
FDA approves Sandoz hypertension drug

The Food and Drug Administration has approved a generic heart disease drug made by Sandoz, the company said.

May 22, 2013
Par ships authorized generic cardiovascular drug

Generic drug maker Par Pharmaceutical Cos. has started shipping an authorized generic version of a heart-disease medication made by AstraZeneca.

May 10, 2013
FDA approves Novartis' Ilaris for rare childhood arthritis

The Food and Drug Administration has approved a biotech drug made by Novartis for treating a form of arthritis that affects children, the Swiss drug maker said Friday.

April 24, 2013
Parents often complicit in teens' prescription drug abuse, study finds

A dramatic jump in the rates of misuse of prescription stimulants over the past four years is linked to lax attitudes on the part of parents, according to a new study, though misuse and abuse of prescription opioids has remained flat.

April 23, 2013
Sandoz VP leaves company

Sandoz U.S. Generics Operating Unit VP sales and marketing Rich Tremonte will leave the company.

April 22, 2013
FDA approves Alcon's Simbrinza

The Food and Drug Administration has approved a drug made by Alcon, the drug maker said.

April 17, 2013
Sandoz launches generic cardiovascular disease drug

Generic drug maker Sandoz has launched a generic version of a drug used to treat high blood pressure and angina.

April 4, 2013
Dr. Reddy's launches generic osteoporosis drug

Dr. Reddy's Labs has launched zoledronic acid injection in the 5 mg-per-100-mL strength, the Indian generic drug maker Thursday.

April 4, 2013
Reports: Novartis launches new ad campaign aimed at young adults

Novartis is promoting the multiple sclerosis drug Gilenya to young people with a new ad campaign in several national magazine's and websites, according to published reports.

April 2, 2013
Reports: Indian Supreme Court strikes down leukemia drug patent

A ruling by India's high court means cheaper generic versions of a cancer drug will remain available in developing countries, according to published reports.

March 25, 2013
FDA approves Novartis antibacterial treatment for cystic fibrosis

The Food and Drug Administration has approved a treatment for managing a type of bacterial infection in patients with cystic fibrosis.

March 20, 2013
Sandoz launches generic contraceptives

The Food and Drug Administration has approved and launched two generic contraceptives made by Sandoz, the drug maker said.

March 12, 2013
Actavis seeks approval for Alzheimer's patch

Actavis is challenging Novartis' patent on a patch used to treat Alzheimer's disease, Actavis said.

March 8, 2013
Branded pain relief tablets battle for sales

With private label across analgesics up an estimated 11.3% to $1.7 billion, retailers are going to need to make some tough decisions as two internal analgesic powerhouses — McNeil's Tylenol and Novartis' Excedrin — make their way back onto market after respective recalls.

March 5, 2013
Dr. Reddy's launches generic cancer drug

Generic drug maker Dr. Reddy's Labs has launched a drug used to treat certain cancers, the company said Tuesday.

February 25, 2013
FDA approves Bayer's Stivarga for gastrointestinal stromal tumors

The Food and Drug Administration has approved a new drug made by Bayer HealthCare Pharmaceuticals for treating tumors of the digestive system, the agency said Monday.

February 8, 2013
FDA gives tentative approval to Dr. Reddy's hypertension drug

The Food and Drug Administration has given tentative approval to a generic drug for treating hypertension, according to agency records.

February 6, 2013
FDA approves Sandoz antibiotic

The Food and Drug Administration has approved a generic antibiotic made by Sandoz, the drug maker said Wednesday.

February 1, 2013
Novartis recalls Triaminic Syrups and Theraflu Warming Relief Syrups

Novartis Consumer Health on Thursday voluntarily issued a recall of certain lots of Triaminic Syrups and Theraflu Warming Relief Syrups that were manufactured in the United States prior to Dec. 31, 2011.

January 25, 2013
FDA approves Gleevec for most common pediatric cancer

The Food and Drug Administration has approved a Novartis drug for treating leukemia in children.

January 23, 2013
FDA approves Novartis drug for rare blood disorder

The Food and Drug Administration has approved a new drug for removing excess iron from the blood in patients with a rare genetic disorder, the agency said.

January 23, 2013
Novartis, Cytos terminate licensing agreement for smoking-cessation drug

Cytos Biotechnology will regain rights to an experimental vaccine against nicotine addiction that it had licensed to Novartis, Cytos said Wednesday.

January 3, 2013
Ranbaxy preserves exclusivity period for generic hypertension drug

A court has ruled in favor of Indian generic drug maker Ranbaxy Labs in a case concerning a generic blood pressure drug, the legal firm representing the drug maker said.

December 28, 2012
Mylan generic heart drug suit against FDA dismissed

A federal judge in Washington has dismissed a suit against the FDA brought up by Mylan for withholding approval for the company to sell a generic version of Novartis AG’s heart pill, Diovan.

December 17, 2012
FDA approves Novartis drug for Cushing's disease

The Food and Drug Administration has approved a new drug to treat a rare but serious endocrine disorder.

© 2013 Drug Store News. All Rights Reserved.